[HTML][HTML] Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity

A Falanga, M Marchetti - Journal of Thrombosis and Haemostasis, 2023 - Elsevier
Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …

Cancer-Associated Thrombosis: Enhanced awareness and pathophysiologic complexity.

A Falanga, M Marchetti - Journal of Thrombosis and Haemostasis …, 2023 - europepmc.org
Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …

[引用][C] Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity

A Falanga, M Marchetti - Journal of Thrombosis and Haemostasis, 2023 - cir.nii.ac.jp
Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …

Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity

A Falanga, M Marchetti - Journal of thrombosis and …, 2023 - pubmed.ncbi.nlm.nih.gov
Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …

Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity

A Falanga, M Marchetti - Journal of Thrombosis and Haemostasis, 2023 - jthjournal.org
Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …